Related Experiment Videos
Drug resistant tuberculosis in prisons in Azerbaijan: case study
R Coninx1, G E Pfyffer, C Mathieu
1International Committee of the Red Cross, CH-1202 Geneva, Switzerland. rconinx@icrc.org
BMJ (Clinical Research Ed.)
|June 6, 1998
Summary
Drug-resistant tuberculosis is common in Azerbaijan prisons. This study found high rates of multidrug-resistant Mycobacterium tuberculosis strains, posing a significant public health risk within correctional facilities and the community.
Area of Science:
- Public Health
- Infectious Diseases
- Microbiology
Background:
- The Directly Observed Treatment, Short Course (DOTS) strategy is a global standard for tuberculosis control.
- Prisons are recognized as high-risk environments for infectious disease transmission.
- Limited data exists on drug resistance patterns in tuberculosis patients within former Soviet Union prison systems.
Observation:
- A case study was conducted at the Central Penitentiary Hospital in Baku, Azerbaijan.
- The study included 28 non-responding tuberculosis patients and 38 newly admitted patients.
- Mycobacterium tuberculosis drug resistance was assessed from sputum samples.
Findings:
- All 28 non-responding patients exhibited drug-resistant tuberculosis strains.
- 89% of non-responding patients and 24% of newly admitted patients had strains resistant to both isoniazid and rifampicin.
- 17 newly admitted patients had strains resistant to at least one first-line anti-tuberculosis drug.
Implications:
- High prevalence of drug-resistant tuberculosis in Azerbaijan prisons necessitates targeted interventions.
- Prisoners and former prisoners can contribute to community transmission of drug-resistant tuberculosis.
- National tuberculosis control programs must integrate strategies to address the unique challenges within prison settings.